Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    July 2017
  1. MENG X, Liu Y, Zhang J, Teng F, et al
    PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges.
    Cancer Lett. 2017 Jul 6. pii: S0304-3835(17)30415.
    PubMed     Text format     Abstract available


    June 2017
  2. BROCK M, Mei Y
    Protein functional effector sncRNAs (pfeRNAs) in lung cancer.
    Cancer Lett. 2017 Jun 19. pii: S0304-3835(17)30394.
    PubMed     Text format     Abstract available


  3. CHANG TH, Tsai MF, Gow CH, Wu SG, et al
    Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Cancer Lett. 2017;402:190-202.
    PubMed     Text format     Abstract available


  4. CHANG YC, Chan YC, Chang WM, Lin YF, et al
    Feedback regulation of ALDOA activates the HIF-1alpha/MMP9 axis to promote lung cancer progression.
    Cancer Lett. 2017;403:28-36.
    PubMed     Text format     Abstract available


  5. KWON OS, Hong SK, Kwon SJ, Go YH, et al
    BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.
    Cancer Lett. 2017 Jun 10. pii: S0304-3835(17)30355.
    PubMed     Text format     Abstract available


    May 2017
  6. CASTANON E, Soltermann A, Lopez I, Roman M, et al
    The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
    Cancer Lett. 2017 May 24. pii: S0304-3835(17)30342.
    PubMed     Text format     Abstract available


  7. ZHANG J, Kong L, Jiao Q, Li M, et al
    Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead.
    Cancer Lett. 2017 May 16. pii: S0304-3835(17)30311.
    PubMed     Text format     Abstract available


    April 2017
  8. WANG Y, Zhou Y, Tao F, Chai S, et al
    N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
    Cancer Lett. 2017 Apr 26. pii: S0304-3835(17)30292.
    PubMed     Text format     Abstract available


    March 2017
  9. LI K, Mo C, Gong D, Chen Y, et al
    DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of beta-catenin.
    Cancer Lett. 2017 Mar 1. pii: S0304-3835(17)30146.
    PubMed     Text format     Abstract available


    February 2017
  10. LI Y, Sun N, Lu Z, Sun S, et al
    Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Cancer Lett. 2017 Feb 18. pii: S0304-3835(17)30125.
    PubMed     Text format     Abstract available


  11. WANG Y, Fu L, Cui M, Wang Y, et al
    Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1.
    Cancer Lett. 2017 Feb 12. pii: S0304-3835(17)30078.
    PubMed     Text format     Abstract available


    January 2017
  12. WANG J, Wang Y, Mei H, Yin Z, et al
    The BET Bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21.
    Cancer Lett. 2017 Jan 28. pii: S0304-3835(17)30072.
    PubMed     Text format     Abstract available


    December 2016
  13. LIN TS, Lee H, Chen RA, Ho ML, et al
    Corrigendum to "An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection" [Cancer Lett. 226 (1) (2005 Aug 8) 77-84].
    Cancer Lett. 2016 Dec 27. pii: S0304-3835(16)30788.
    PubMed     Text format    


    November 2016
  14. MOURONTE-ROIBAS C, Leiro-Fernandez V, Fernandez-Villar A, Botana-Rial M, et al
    COPD, emphysema and the onset of lung cancer. A systematic review.
    Cancer Lett. 2016;382:240-244.
    PubMed     Text format     Abstract available


    August 2016
  15. CHEN H, Cong Q, Du Z, Liao W, et al
    Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Cancer Lett. 2016 Aug 26. pii: S0304-3835(16)30495.
    PubMed     Text format     Abstract available


  16. PARK SJ, Choi YS, Lee S, Lee YJ, et al
    BIX02189 inhibits TGF-beta1-induced lung cancer cell metastasis by directly targeting TGF-beta type I receptor.
    Cancer Lett. 2016;381:314-322.
    PubMed     Text format     Abstract available


    July 2016
  17. ONG PS, Wang L, Chia DM, Seah JY, et al
    A novel combinatorial strategy using Seliciclib(R) and Belinostat(R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation.
    Cancer Lett. 2016 Jul 25. pii: S0304-3835(16)30440.
    PubMed     Text format     Abstract available


  18. YI C, Wang Y, Zhang C, Xuan Y, et al
    Cleavage and polyadenylation specific factor 4 targets NF-kappaB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Cancer Lett. 2016;381:1-13.
    PubMed     Text format     Abstract available


  19. SHI P, Oh YT, Zhang G, Yao W, et al
    Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
    Cancer Lett. 2016;380:494-504.
    PubMed     Text format     Abstract available


  20. HONG SK, Park JR, Kwon OS, Kim KT, et al
    Induction of integrin beta3 by sustained ERK activity promotes the invasiveness of TGFbeta-induced mesenchymal tumor cells.
    Cancer Lett. 2016;376:339-46.
    PubMed     Text format     Abstract available


    June 2016
  21. HOU J, Wang T, Xie Q, Deng W, et al
    N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-kappaB/p65.
    Cancer Lett. 2016;376:22-33.
    PubMed     Text format     Abstract available


  22. LENG C, Zhang ZG, Chen WX, Luo HP, et al
    An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Cancer Lett. 2016;376:188-96.
    PubMed     Text format     Abstract available


  23. SHOU J, You L, Yao J, Xie J, et al
    Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
    Cancer Lett. 2016 Jun 2. pii: S0304-3835(16)30359.
    PubMed     Text format     Abstract available


  24. COTRONEO CE, Dassano A, Colombo F, Pettinicchio A, et al
    Expression quantitative trait analysis reveals fine germline transcript regulation in mouse lung tumors.
    Cancer Lett. 2016;375:221-30.
    PubMed     Text format     Abstract available


    May 2016
  25. LI Q, Liu Z, Xu M, Xue Y, et al
    PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.
    Cancer Lett. 2016;375:190-8.
    PubMed     Text format     Abstract available


  26. DUAN B, Cui J, Sun S, Zheng J, et al
    EGF-stimulated activation of Rab35 regulates RUSC2-GIT2 complex formation to stabilize GIT2 during directional lung cancer cell migration.
    Cancer Lett. 2016 May 26. pii: S0304-3835(16)30340.
    PubMed     Text format     Abstract available


  27. SZPECHCINSKI A, Rudzinski P, Kupis W, Langfort R, et al
    Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.
    Cancer Lett. 2016;374:202-7.
    PubMed     Text format     Abstract available


    April 2016
  28. LV YF, Dai H, Yan GN, Meng G, et al
    Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3beta/beta-catenin/Snail signaling pathway.
    Cancer Lett. 2016;373:164-73.
    PubMed     Text format     Abstract available


  29. LEE CC, Yang WH, Li CH, Cheng YW, et al
    Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
    Cancer Lett. 2016 Apr 6. pii: S0304-3835(16)30213.
    PubMed     Text format     Abstract available


    March 2016
  30. LIN TY, Hsu HY
    Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation.
    Cancer Lett. 2016 Mar 15. pii: S0304-3835(16)30166.
    PubMed     Text format     Abstract available


  31. DEBEN C, Lardon F, Wouters A, Op de Beeck K, et al
    APR-246 (PRIMA-1) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines.
    Cancer Lett. 2016 Mar 11. pii: S0304-3835(16)30165.
    PubMed     Text format     Abstract available


  32. ZHANG Z, Xiaomei R, Xiaoyun L, Deping W, et al
    GZD856, a novel potent PDGFRalpha/beta inhibitor, suppresses the growth and migration of lung cancer cells in vitro and in vivo.
    Cancer Lett. 2016 Mar 1. pii: S0304-3835(16)30071.
    PubMed     Text format     Abstract available


    February 2016
  33. KAWPRASERTSRI S, Pietras RJ, Marguez-Garban DC, Boonyaratanakornkit V, et al
    Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.
    Cancer Lett. 2016 Feb 15. pii: S0304-3835(16)30068.
    PubMed     Text format     Abstract available


  34. MUNAGALA R, Aqil F, Jeyabalan J, Gupta RC, et al
    Bovine milk-derived exosomes for drug delivery.
    Cancer Lett. 2016;371:48-61.
    PubMed     Text format     Abstract available


    January 2016
  35. MACDONAGH L, Gray SG, Breen E, Cuffe S, et al
    Lung cancer stem cells: The root of resistance.
    Cancer Lett. 2016 Jan 18. pii: S0304-3835(16)00024.
    PubMed     Text format     Abstract available


  36. LIU Y, Luo F, Wang B, Li H, et al
    STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells.
    Cancer Lett. 2016;370:125-35.
    PubMed     Text format     Abstract available


    December 2015
  37. PARK KS, Oh B, Lee MH, Nam KY, et al
    The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.
    Cancer Lett. 2015 Dec 23. pii: S0304-3835(15)00766.
    PubMed     Text format     Abstract available


  38. KAUR G, Reinhart RA, Monks A, Evans D, et al
    Bromodomain and hedgehog pathway targets in small cell lung cancer.
    Cancer Lett. 2015 Dec 10. pii: S0304-3835(15)00737.
    PubMed     Text format     Abstract available


  39. GUO H, Liu S, Guo J, Li B, et al
    Rapid on-site evaluation during endobronchial ultrasound-guided transbronchial needle aspirates for the diagnosis of hilar and mediastinal lymphadenopathy in patients with lung cancer.
    Cancer Lett. 2015 Dec 4. pii: S0304-3835(15)00728.
    PubMed     Text format     Abstract available


  40. NIE W, Ge HJ, Yang XQ, Sun X, et al
    LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
    Cancer Lett. 2015 Dec 3. pii: S0304-3835(15)00700.
    PubMed     Text format     Abstract available


  41. DE AGUIAR RB, Parise CB, Souza CR, Braggion C, et al
    Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.
    Cancer Lett. 2015 Dec 3. pii: S0304-3835(15)00720.
    PubMed     Text format     Abstract available


  42. SACHDEVA M, Dodd RD, Huang Z, Grenier C, et al
    Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.
    Cancer Lett. 2015;369:202-11.
    PubMed     Text format     Abstract available


    November 2015
  43. XU S, Lou F, Wu Y, Sun DQ, et al
    Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients.
    Cancer Lett. 2015 Nov 12. pii: S0304-3835(15)00679.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: